Last reviewed · How we verify
GDC-0810 Phase III Prototype Tablet
At a glance
| Generic name | GDC-0810 Phase III Prototype Tablet |
|---|---|
| Sponsor | Genentech, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study to Investigate the Effect of Formulation and Food on the Pharmacokinetics of GDC-0810 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |